Details
Category: Volume 07 Issue 07 July 2019
Hits: 1553

Title: An Outlook on Cost Analysis among Common Oral Antihypertensive Medications of various Brands Available in Indian Pharmaceutical Companies

Authors: B. Jagan Nathan, S. Sabishruthi, S. Kavitha, S. Sindhu, S.Punitha

 DOI: https://dx.doi.org/10.18535/jmscr/v7i7.18

Abstract

Aim: The current study was performed to analyse the percentage of cost variations of commonly prescribing antihypertensive medications among different brands of same drugs in India.

Materials and Methods: The data of cost of commonly used antihypertensive drugs were collected from CIMS and IDR, which may provide accurate drug information. Additionally the drug prices are also checked in retail pharmacy. Data about the cost of oral antihypertensive drugs were collected as cost per 10 tablets in same strength and same dosage forms that was manufactured from different companies and they were compared to find the variation of cost. Combinations of drugs were excluded from the study. Cost ratio and percentage of cost were calculated using applicable formulae.

Results: Out of 23 drugs of different doses without combination Tablet Amlodipine (5 mg) shows the maximum price variation of 460%, followed by Tablet Enalapril  (10 mg) 374.28%, Tablet Olmesartan (20 mg) 404.41%, Tablet Amlodipine (5 mg) 460% and Tablet Atenolol 100 mg 424.66% variation.

Conclusion: The study reveals that there was a huge variation of cost in drugs which was manufactured from various pharmaceutical companies. Hence physicians can prescribe the drugs in generic forms. An awareness must be created about the maximum variation of cost to the physicians, pharmacist and health care management to our economic benefits for patients and increase their benefits of therapy.

Keywords: Cost, Antihypertensive drugs, Brands, Physician, Benefits.

References

  1. Rajan AK, Sabishruthi S, Manivendra G, Benita ES, Mukesh M. Appraisal of Health Related Quality of Life Among Hypertensive Patients in A Tertiary Care Hospital in South India. International Journal of Current Innovation Research.2018; 4(11): 1401-1404.
  2. Nair MK, Neha MS. Cost variation analysis of antihypertensive drugs acting through renin angiotensin aldosterone axis modulation. Int J Basic ClinPharmacol. 2017;6:1085-9.
  3. Kumar R, Manu C, Singh DJ, Lakhani P, Tutu S, Dixit R. The extent of price variation amongst branded antihypertensive drugs and its association with number of pharmaceutical companies. Int J Res Med Sci. 2015;3:2800-6.
  4. Moran AE et al. Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines. N Engl J Med. 2015; 372(5): 447-455.
  5. Ce´sar Gonzalo Calvo-Vargas, Jose´ Z. Parra Carrillo, Fernando Grover Pa´ez, and Salvador Fonseca Reyes. Changes in the Costs of Antihypertensive Medications in a Developing Country A Study in Mexico Comparing 1990 and 1996. AJH. 1998;11:487–493.
  6. Rachana PR, Anuradha HV, MC Shivamurthy.Anti Hypertensive Prescribing Patterns and Cost Analysis for Primary Hypertension: A Retrospective Study. Journal of Clinical and Diagnostic Research. 2014; 8(9): 19-22.
  7. Kullgren JT, Segel JE, Peterson TA, Fendrick AM, Singh S. Availability and Variation of Publicly Reported Prescription Drug Prices.Am J Manag Care. 2017;23(7):444-448.
  8. ShubhamAtal, SarjanaAtal, DeshmankarB, Nawaz SA. Cost Analysis Of Commonly Used Drugs Under Price Control In India: Assessing The Effect Of Drug Price Control Order On Brand Price Variation. Int J Pharm Pharm Sci. 2016; 8(4): 315-321.
  9. Mamatha K.R, Vishnu K. Cost variation analysis of various brands of oral hypolipidemic drugs available in Indian pharmaceutical market. Int. J. of Res. in Pharmacology &Pharmacotherapeutics. 2017; 6(3): 381-388.
  10. Kamath L and Satish GR. Cost Variation Analysis of Antihypertensive Drugs Available in Indian Market: An Economic Perspective. Int J Pharm Sci Res. 2016; 7(5): 2050-56.
  11. Chawan VS, Badwane SV, Gawand KV, Chhaya MU. Analysis of price variation amongst different formulations of anxiolytic drugs available in Indian market. Int J Res Med Sci. 2016;4:2398-401.
  12. Chandrappa S, Rajarathna K. Cost variation analysis of various brands of topical eye preparations currently available in Indian pharmaceutical market. Int J Basic ClinPharmacol. 2018;7:2364-7.
  13. Jadhao T, Advani M, Jamdade S. Cost variation analysis of antiglaucoma drugs available in Indian market. Paripex - Indian Journal of Research. 2017; 6(2): 42-43.
  14. Chaudhari A, Zaveri JR. Pharmacoeco-economic study: A cost variation analysis of AKT drugs available in Indian market. Indian J Pharm Pharmacol. 2019; 6(1): 6-10.
  15. Lakdawala A. Cost variation analysis of oral hypolipidemic drugs available in Indian market. International Journal of Research and Review. 2018; 5(9):1-4.
  16. Bhanu Prakash kolaSani1, Divya Shanthi Chellatham Bimalathi2, raghunatharao Ponnaluri3. Variation of Cost among Anti-cancer Drugs Available in Indian Market. Journal of Clinical and Diagnostic Research. 2016; 10(11): 17-20.
  17. Bhandari PR. Analysis of Cost Variation of Hypolipidemics. J Pharm Biomed Sci. 2019; 09(04): 35-42.
  18. Shrestha B. Cost analysis of oral antihypertensive agents available in Nepal. Journal of Institute of Medicine. 2015; 37(2): 27-31.

Corresponding Author

S Sabishruthi

Department of Pharmacy Practice, Jaya College of Paramedical Sciences, College of Pharmacy, Thiruninravur, Chennai – 602024, India